Medial EarlySign announced Thursday that it has entered a collaboration with Roche to implement artificial intelligence (AI) for the early detection of lung cancer.
The goal is to deliver validated clinical machine learning models for lung cancer detection with EarlySign's LungFlag technology. The technology uses a variety of signals, including basic demographic, medical, drug, and routine clinical lab data.
The collaboration builds upon an existing agreement that has focused on the development of a personalized health solution for the early detection of gastric cancer.
